Aureus Asset Management LLC Sells 305 Shares of Zoetis Inc. (NYSE:ZTS)

Aureus Asset Management LLC lessened its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 16.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,558 shares of the company’s stock after selling 305 shares during the period. Aureus Asset Management LLC’s holdings in Zoetis were worth $304,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ZTS. Mather Group LLC. boosted its position in shares of Zoetis by 19.4% in the second quarter. Mather Group LLC. now owns 3,527 shares of the company’s stock valued at $597,000 after acquiring an additional 573 shares during the period. CVA Family Office LLC raised its stake in Zoetis by 13.5% during the 2nd quarter. CVA Family Office LLC now owns 1,191 shares of the company’s stock valued at $206,000 after purchasing an additional 142 shares during the last quarter. NBC Securities Inc. boosted its holdings in Zoetis by 32.1% in the 2nd quarter. NBC Securities Inc. now owns 9,797 shares of the company’s stock valued at $1,698,000 after purchasing an additional 2,383 shares during the period. Valeo Financial Advisors LLC grew its position in Zoetis by 4.6% in the 2nd quarter. Valeo Financial Advisors LLC now owns 7,937 shares of the company’s stock worth $1,376,000 after purchasing an additional 348 shares during the last quarter. Finally, Csenge Advisory Group raised its position in shares of Zoetis by 1.3% during the second quarter. Csenge Advisory Group now owns 5,700 shares of the company’s stock valued at $988,000 after buying an additional 71 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of recent research reports. BTIG Research lifted their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. boosted their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Leerink Partners assumed coverage on Zoetis in a research report on Monday. They issued an “outperform” rating and a $215.00 target price for the company. Piper Sandler boosted their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Finally, Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Eleven analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $220.80.

Zoetis Price Performance

Shares of Zoetis stock opened at $176.81 on Tuesday. The stock has a market capitalization of $79.77 billion, a price-to-earnings ratio of 33.24, a P/E/G ratio of 2.69 and a beta of 0.89. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The firm’s 50-day moving average price is $183.83 and its two-hundred day moving average price is $180.97. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the previous year, the company earned $1.36 EPS. Zoetis’s revenue was up 11.6% on a year-over-year basis. On average, equities analysts predict that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a $0.432 dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. Zoetis’s dividend payout ratio (DPR) is 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.